FIELD: cell biology; medicine.
SUBSTANCE: present invention relates to cell biology and medicine, in particular to a combination of natural killer cells (hereinafter – NK) or a line of NK cells, providing a cytotoxic effect, with an antibody-antagonist relatively to IL-6R and a method for the treatment of blood cancer, the cells of which express IL-6R, using the specified combination.
EFFECT: present invention allows for the improvement of efficiency and improvement of therapy of blood cancer, the cells of which express IL-6R.
51 cl, 70 dwg, 1 tbl, 11 ex
| Title |
Year |
Author |
Number |
| MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES WITH INCREASED CYTOTOXICITY |
2016 |
- O`Dvajer, Majkl Imon Piter
|
RU2772348C2 |
| METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS |
2005 |
- Godovski Pol Dzh.
- Satial Sandzhiv Kh.
|
RU2395294C2 |
| ANALYSES AND METHODS WITH APPLICATION OF BIOMARKERS |
2005 |
|
RU2431676C2 |
| ANALYSES AND METHODS USING BIOMARKERS |
2005 |
|
RU2410438C2 |
| METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE |
2019 |
- Shpall, Elizabeth
- Rezvani, Katy
|
RU2814083C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTITUMOUR EFFECT, AND METHOD FOR REDUCING PD-L1 INHIBITING EFFECT ON HUMAN T-CELLS |
2016 |
|
RU2688692C2 |
| ANALYSES AND METHODS OF BIOMARKER APPLICATION |
2006 |
- Vagner Klaus V.
- Ashkenazi Avi Dzh.
|
RU2409817C2 |
| CHIMERIC ANTIGEN RECEPTOR WITH COSTIMULATORY DOMAIN 4-1BB |
2020 |
- Kwon, Byoung S.
- Kim, Kwanghee
- Chung, Jiwon
- Chang, Young Gyoon
- Yi, Bo-Rim
- Lee, Jungyun
- Lee, Sae Rom
- Son, Hyuntae
- Lee, Hye Mi
- Yoo, Eun Hye
|
RU2830540C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS |
2018 |
|
RU2800922C2 |
| APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES |
2006 |
- Vagner Klaus V.
- Ashkenazi Avi Dzh.
|
RU2416097C2 |
